MEDIFAST INC(MED)

upturn advisory logo
ADVISORIES YOU CAN VERIFY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 14 days
PROFIT SINCE LAST BUY
+0.08% ▲
LAST CLOSE
$12.17
09/25/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close

Advisory Performance History (Simulated)Advisory Performance History info

Upturn Advisory & Investor View for MED

09/25/2026: MED (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Medifast Inc. is a health and wellness company primarily known for its OPTAVIA brand, which utilizes an independent coach-led model to provide weight management programs. The company historically achieved growth through this direct-selling platform, successfully building a loyal customer base. Currently, Medifast faces significant challenges as consumers shift toward pharmaceutical GLP-1 weight-loss alternatives, impacting demand for traditional diet programs. Its primary investment story hinges on whether the company can successfully pivot its business model to remain relevant in a medically-influenced weight-loss market. The stock may interest value-oriented investors monitoring business stabilization, though high volatility and intense competitive headwinds make it a cautious play for many.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitCurrent growth trajectory is challenged by significant market shifts toward pharmaceutical alternatives.
Momentum investorWeak fitThe stock lacks the positive momentum signal typically sought by this style.
Value investorMixed fitValuation may appear attractive to some, but requires confidence in business model stabilization.
Dividend investorMixed fitDividend sustainability depends heavily on the company's ability to maintain earnings during this transition period.
Low-risk investorWeak fitHigh volatility and competitive headwinds make this unsuitable for risk-averse portfolios.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock has experienced significant price swings reflecting changing market sentiment.
Valuation riskMedium / highUncertainty regarding future earnings makes valuation multiples difficult to justify.
Competition risk (GLP-1/Medical)HighThe rapid rise of medical weight-loss solutions is a primary existential risk.
Business qualityMediumThe reliance on a direct-selling coach model faces structural challenges in the current retail environment.
Dividend incomeMedium / highFuture dividend payments are subject to board approval and financial performance.
Execution riskHighTurning around the business model amidst intense competition requires flawless execution.

Price Behavior

Steady Uptrend
PRICE PATH

Steady Uptrend

The stock demonstrates consistent and steady upward price momentum.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -38.21%
Avg. Invested days 20
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 09/25/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
MED receives a 2-star rating, supported by available scored pillars. The rating is constrained by soft unit economics, soft analyst coverage, and weak price momentum.

Company Fundamentals

★★★★★
MED has moderate overall fundamentals (3 stars), with moderate financial health, weak growth momentum, and solid ownership. In FY2025 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-993.0%), soft cash generation (FCF margin 0.3%), negative revenue growth (-36.0%).

Financial Health Rating

★★★★★
MED's financial health is supported by solid liquidity, including working-capital and asset support (WC/assets 61.8%). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
MED's growth profile is soft, with the least-weak measure being revenue growth at -36.0% FY2025 versus FY2024. By comparison, while earnings growth (-993.0%, negative) and free-cash-flow growth (-92.7%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 75.3% and approximately 75.5% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 4.33% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 8.45%
Renaissance Technologies Corp 6.92%
Steamboat Capital Partners, LLC 6.32%
Charles Schwab Investment Management Inc 5.65%
Two Sigma Investments LLC 4.31%

Unit Economics (Per $1K Revenue)

★★★★★
MED generates approximately $713 of gross profit, $-37 of operating income, and $3 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong cash conversion and healthy margins support the rating, although capital efficiency remains below the highest tier.

Economic Dimensions

★★★★★
Effective Tax Rate: -231.12% (Tax Credit)

Quantitative Style Profile

★★★★★
MED has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 136.07M USD
Price to earnings Ratio -
1Y Target Price 12
Price to earnings Ratio -
1Y Target Price 12
Volume (30-day avg) 119.6K shares
Beta 0.73
52 Weeks Range 9.22 - 14.15
Updated Date 09/26/2026
52 Weeks Range 9.22 - 14.15
Updated Date 09/26/2026
Dividends yield (FY) -
Basic EPS (TTM) -2.33

How Company Makes Money

Business areaWhat it includesRetail investor read
OPTAVIA ProgramSale of proprietary Fuelings and subscription-based access to the coaching network.The company relies on customers consistently purchasing branded food products while participating in a coach-led support program.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Advertisement

Valuation

Trailing PE -
Forward PE 12.48
Enterprise Value 642.84K
Price to Sales(TTM) 0.43
Enterprise Value 642.84K
Price to Sales(TTM) 0.43
Enterprise Value to Revenue 0.01
Enterprise Value to EBITDA 0.05
Shares Outstanding 11.18M
Shares Floating 8.44M
Shares Outstanding 11.18M
Shares Floating 8.44M
Percent Insiders 4.33
Percent Institutions 75.34

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI Summary

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

About MEDIFAST INC

Exchange NYSE
Headquarters Baltimore, MD, United States
IPO Launch date 1993-12-31
CEO & President Mr. Nicholas M. Johnson
Sector Consumer Cyclical
Industry Personal Services
Full time employees 380
Full time employees 380

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.